Clinical outcomes of patients with metastatic renal cell carcinoma who discontinued nivolumab +/- ipilimumab therapy electively or due to toxicity.

Autor: Yoo, Jessica Heejin, Hussey, Duncan, Gross, Evan, Psutka, Sarah P., Tykodi, Scott S., Thompson, John A., Hall, Evan Thomas
Zdroj: Journal of Clinical Oncology; 2/21/2023 Supplement, Vol. 41, p625-625, 1p
Databáze: Supplemental Index